ASCO 2019

Showing 3 posts of 3 posts found.

abbvie_0

AbbVie’s Venclyxto combo outclasses chemo in treatment-naive chronic lymphocytic leukaemia

June 5, 2019
Research and Development ASCO 2019, AbbVie, Venclyxto, pharma

AbbVie was one of many companies to present new data at this year’s American Society of Clinical Oncology (ASCO) Annual …

shutterstock_159488225

Darzalex combo makes strong Phase 3 showing in multiple myeloma

June 4, 2019
Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma

Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …

janssen_latest_logo_on_sign_closer

Janssen’s Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer

June 3, 2019
Research and Development, Sales and Marketing ASCO 2019, Cancer, Erleada, Janssen, prostate cancer

Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new …

Latest content